Status:
NOT_YET_RECRUITING
Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders
Lead Sponsor:
Sohag University
Conditions:
Toxoplasmosis in Neuropsychiatric Disorders
Eligibility:
All Genders
Up to 15 years
Brief Summary
Toxoplasma gondii is recognized as being involved in the etiology of various psychotic disorders including epilepsy and ADHD (Markovitz et al.,2015). There are many explanations for such associations...
Eligibility Criteria
Inclusion
- Inclusion criteria: Children with neuropsychiatric disorders (epilepsy,ADHD). Exclusion criteria: Children with history of neurosurgery, head injury or trauma, neoplastic or autoimmune diseases, or receiving immunosuppressant or systemic corticosteroid, and those with possible neurological infection.
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06980298
Start Date
June 1 2025
End Date
February 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt